Discontinuation of Automated Engagement Support

NCT02578628 | Terminated

• 1 other identifier: 15-453
• Study Type: interventional
• Target: 488
• Locations: 1 country
• Sites: 1

Brief Summary

The Chronic Kidney Disease Engagement System is currently in place for 1700 adults receiving care from Empire Physicians Medical Group (EPMG), an Independent Practice Association located in Palm Desert, California. The system monitors routine clinical laboratory test results and send messages to patients and providers when action is indicated, such as when tests are overdue or results require extra clinical attention. This study will assess what happens to laboratory results, utilization of laboratory tests, and costs of care when ther system is discontinued.

Conditions

Chronic Kidney Disease

Outcome Measures

Primary Outcomes (1)

• Claims paid in past 12 months for covered services

  Total and breakdown by categories

  3 years

Secondary Outcomes (10)

• Lipid test completed within time allotted per disease stage

  3 years

• Estimated glomerular filtration

  3 years

• Hemoglobin test completed within time allotted per disease stage

  3 years

• Serum calcium test completed within time allotted per disease stage

  3 years

• Serum phosphorus test completed within time allotted per disease stage

  3 years

Study Arms (2)

Active

ACTIVE COMPARATOR

These subjects will continue to receive Patient Engagement services.

Other: Patient Engagement

Control

NO INTERVENTION

These patients will have all Patient Engagement services discontinued.

Interventions

Patient Engagement OTHER

The patient engagement system monitors routine clinical laboratory test results and sends messages to patients and providers when action is indicated, such as when tests are overdue or results require extra clinical attention. Patients receive first class letters directing them to call their provider. Providers receive fax or electronic messages directing them to reach out to the patient to arrange follow-up care.

Active

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Receiving services from Patient Engagement Services at randomization. CKD Stages 1, 2 or 3. Under the care of Empire Physicians Medical Group of Palm Desert, California.

You may not qualify if:

• Patient refusal.

Sponsors & Collaborators

• University of Vermont: lead
• Patient Engagement Systems: collaborator
• Empire Physicians Medical Group: collaborator

Study Sites (1)

Empire Physicians Medical Group

Palm Desert, California, 92211, United States

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Benjamin Littenberg, MD

  University of Vermont

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Medicine

Study Record Dates

• First Submitted: October 10, 2015
• First Posted: October 19, 2015
• Study Start: October 1, 2015
• Primary Completion: December 31, 2017
• Study Completion: December 31, 2017
• Last Updated: May 8, 2018

Record last verified: 2018-05

Locations

US (1)